U.S. and international enforcement authorities have continued their vigorous pursuit of life sciences companies for FCPA and anti-corruption violations, resulting in recent high profile investigations across the globe and heightened government compliance expectations.
In response to this daunting climate, ACI’s 10th Advanced Conference on FCPA & Anti-Corruption for the Life Sciences Industry provides a forum for the key players - top federal prosecutors, preeminent corporate counsel, and leading FCPA practitioners - to come together for critical networking and benchmarking on how to combat the next wave of global anti-corruption risk factors confronting the industry.
Updates on CRO Compliance: The Latest Best Practices for Minimizing Pre- and Post- Market Corruption Risks
Thursday, April 28, 2016 | 1:30 pm-2:30 pm
Eric Kraeutler | Partner – Morgan, Lewis & Bockius LLP
Keir Strauss | Assistant General Counsel, Compliance & Ethics – INC Research
Gary Giampetruzzi | Partner – Paul Hastings LLP